| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| Q9LNT1 | Kinesin-like protein; | T20H2.17; | NULL | 923 | arabidopsis |
| Q8H7G4 | Pectate lyase; EC 4.2.2.2; Fragment; | NULL | NULL | 193 | arabidopsis |
| Q0WKU9 | MADS-box protein AGL14; | At4g11880; | NP_192925.1; | 221 | arabidopsis |
| W8PUZ4 | Glycosyltransferase; Fragment; | NULL | NP_197685.2; | 469 | arabidopsis |
| Q84W97 | Kinesin-like protein; | At2g47500; | NULL | 983 | arabidopsis |
| B2BDJ4 | Non-expressor of PR1; | NPR1; | NULL | 593 | arabidopsis |
| Q8L891 | Phospholipase D; EC 3.1.4.4; | NULL | NULL | 848 | arabidopsis |
| Q9ZVV2 | Kinesin-like protein; | T5A14.3; At1g55550; | NULL | 887 | arabidopsis |
| Q8GXB6 | Putative uncharacterized protein At4g33110/F4I10_40; | At4g33110/F4I10_40; | NULL | 355 | arabidopsis |
| C0Z288 | AT1G29950 protein; | At1g29950; | NP_564342.1;NP_973937.1; | 251 | arabidopsis |
| B9DFH3 | AT5G55920 protein; Fragment; | At5g55920; | NULL | 625 | arabidopsis |
| Q945B0 | 2-oxoglutarate-dependent dioxygenase; Fragment; | AOP2; | NULL | 404 | arabidopsis |
| Q1PEW5 | Abscisic acid-responsive HVA22 family protein; | At2g36020; | NP_565832.1; | 258 | arabidopsis |
| Q0WW11 | Sucrose export defective 1; | At4g32770; | NP_567906.1; | 488 | arabidopsis |
| Q0WTD0 | Homocysteine S-methyltransferase AtHMT-2; | At3g63250; | NP_191884.1; | 333 | arabidopsis |
| Q0WWR6 | Ferritin; EC 1.16.3.1; | At3g56090; | NP_191168.1; | 259 | arabidopsis |
| Q0WRQ5 | DnaJ homologue; | At5g06910; | NP_196308.1; | 284 | arabidopsis |
| C0Z307 | AT4G16360 protein; | At4g16360; | NULL | 110 | arabidopsis |
| W8Q3A1 | Glycosyltransferase; Fragment; | NULL | NP_181910.1; | 449 | arabidopsis |
| W8PVM7 | Glycosyltransferase; Fragment; | NULL | NP_850150.1; | 610 | arabidopsis |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |